“We’ve heard frequent reports of patients rationing insulin, and in some cases dying because they can’t afford the injections they need to survive,” said FDA Commissioner Scott Gottlieb. “These tragic stories aren’t isolated occurrences. And they’re not acceptable for a drug that’s nearly a century old.”
from Kaiser Health News https://ift.tt/2SL0tGf
December 12, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: August 5, 2019Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2YKHqhI … Read More
Series Of Shootings In Chicago So Overwhelmed Hospital It Had To Stop Accepting PatientsMount Sinai Hospital had to temporarily bypass new patients on the same weekend that two mass shootings rocked the nation. "You have to stop yourself and ask what will it take before we get a handle on what's going on," said … Read More
Kathy Brandt, A Hospice Expert Who Invited The World Into Her Own Last Days With Cancer, Dies… Read More
Medicare Boosts Payment Rates For Pricey New Treatments, But Health Providers Disappointed It’s Not More“Under this plan, I have concern that access to CAR T won’t be universal,” said Jayson Slotnik, a partner at Health Policy Strategies. Some argue Medicare should pay for 80 to 100 percent of the pricey cancer treatment. In ot… Read More
Drugmakers Now ‘Masters’ At Rolling Out Their Own Generics To Stifle Competition… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment